{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJWcgNEJDA","type":"Investor","logokey":"","name":"Arkin Bio","subtype":"VC and Private Equity","lastupdate":"2020-03-09T00:00:00.000Z","update_date":"2020-03-09T00:00:00.000Z","lastModified":"Jun 10, 2025","active":1,"confidence_score":50,"confidence_score_reason":"product stage, sector, number of employees, business model, logo, tag line, video or image, funding rounds, markets, external profiles, not claimed","urlname":"arkin-bio","minimal_profile":null,"hide_reason":null,"status":"Active","fullstatus":"Active","hide_reason_data":null,"acquired":0,"description_edited":0,"tag_line_edited":0,"isisraeli":1,"country":"Israel","formernames":[],"min_date_investments":"2016-04-01T00:00:00.000Z","hide_reasons":[{"id":"71DetFrndkNwNZufhli91PBqJkgDvyWv0skK3yYHYitL6RnFpb2Uf1","reason":"Pending approval - External entity"},{"id":"bMlvNZGgO393OpCQn2LLGyGQIyzd4aZiwm516IvRMWEx6Fkam4LPsQ","reason":"Firm does not match any of Finder’s investors entities"},{"id":"hUspihf43qDmsZbgaEhZKEfAAW3v31Vgv8cpxJzOvLRPPTJ0F4MHzR","reason":"Pending approval"},{"id":"o9Wzo8oG7DIeZVpiC2CdK6IVPWAA4wFvEE97ITVY0oHo6HyeP4v2YV","reason":"Firm asked to delete"},{"id":"rW7l4bkGn6inVBM54t8wGMz9mlLAxGGZOgTQSofPoEagmlofSfwSil","reason":"Foreign, no presence - no Israeli investments/fund"},{"id":"TW4W1IZcqaOGz6jCahuX2wE03SdSzw54lheysaeW0zOAsmOGBFF014","reason":"Foreign, no presence - not enough investments"},{"id":"wcXeLKSl465vLdJtWXjddE1UVQbANeL8NjdsDpAh0CYTtOJw8wHP97","reason":"Firm asked to hide in the meantime"}],"registrar":"515418978","founded_year":2016,"iia_supported":0,"currently_iia_supported":0,"alternativenames":["Arkin Capital"],"managedassets":"Undisclosed","representing":null,"supported_by":"","supported_by_id":"","inisraelsince":"","inisraelsincemonth":"","investment_lower_amount":null,"investment_upper_amount":null,"marketcapital":null,"marketcapitaldate":null,"oneliner":"","website":"https://www.arkinholdings.com/healthcare-investments/pharma-and-biotech/","sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"investmentstage":["Seed","A Round","Pre-Seed"],"about":"Arkin Bio is an activity of Arkin Capital, a multi-billion-dollar VC, PE and Hedge Funds manager, targeting both early-stage and late-stage investments in Israel and around the world. They strategically invest through four main arms – Arkin Health, Arkin Equity, Arkin Tech, and Arkin Real Estate – covering 10 core investment activities and eight dedicated funds.\n\nArkin Bio Ventures identifies, invests in, and accompanies innovative early and mid-stage companies with game-changing breakthroughs in areas such as immunotherapy, cancer, metabolism, microbiome, central nervous system, autoimmune diseases, orphan diseases, and drug-delivery platforms.\n\nArkin Bio Ventures' management team leads and supports its portfolio companies through the hurdles of drug development, towards the proof-of-concept stage and beyond, to significant value creation. \n\nArkin Bio Ventures is currently invested in companies in various stages of product development. Arkin Bio Ventures is a joint venture between insurance and finance company Phoenix Group (49%) and Arkin Holdings (51%). In 2016, the two companies announced a strategic collaboration agreement for investment in pharmaceutical and biotechnology companies, for a total of approximately $60 million (with an option to increase the investment in the future).","founded":"3/2016","education":null,"additional_activities":null,"techcommunityinvolvement":null,"exits":[{"date":"Oct 2023","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"Je7gUzsBzBWLSYmJFmJeKMNyca5vPCyRmJwskLL7Eb9VsNcW45rIvl","mnatype":"Merger","eventtype":"MNAEvent","valuation":"Undisclosed","wasacquired":1,"capitalraised":"Undisclosed","stockexchange":null,"eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"BioSight","acquiredcompany_spac":null,"acquiringcompany_mna":"Ayala Pharmaceuticals","stockexchange_logokey":null,"acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6Y9LoLDA","acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"acquiringcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNrZnJ8LDA","acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_fullurl":"/company_page/biosight","acquiredcompany_mna_logokey":"$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","acquiredcompany_mna_urlname":"biosight","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":0,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":"/company_page/ayala-pharmaceuticals","acquiringcompany_mna_logokey":"$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","acquiringcompany_mna_urlname":"ayala-pharmaceuticals","acquiredcompany_reverse_hidden":null,"acquiredcompany_reverse_fullurl":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"blurFinancialData":"","stockexchange_logourl":"/assets/empty-state.svg","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$3qXch2p2aevQd2Qmpo1H1HSUsFRdIUDzmD1E4Kauj00mt7A5Pc2bl9","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","acquiringcompany_style":"","acquiringcompany_hiddenCompanyTooltip":"","style":"","hiddenCompanyTooltip":""}],"funds":[{"date":"Mar 2020","name":"2","title":"Fund 2","amount":"$140M","source":"https://www.fiercebiotech.com/biotech/arkin-holdings-phoenix-group-unite-again-140m-biotech-fund","eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCOjqv2CQw","visibilitytype":"Public","amountvisibility":"Private","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n Private\n
'","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":""},{"date":"Jun 2016","name":"1","title":"Fund 1","amount":"$60M","source":"https://www.prnewswire.com/news-releases/arkin-holdings-and-phoenix-group-announce-a-strategic-collaboration-that-will-invest-approximately-60-million-in-pharma-and-biotech-companies-583266301.html","eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD2krrhCAw","visibilitytype":"Public","amountvisibility":"Private","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n Private\n
'","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":""}],"portfolio":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMW95ZgKDA","name":"ARTSaVIT","hidden":false,"raised":"$6.3M","founded":"2014","fullurl":"/company_page/artsavit","logokey":"$F6WXD1F4Qwz7mYtJBrGr3m9mOk5BwIkF3CODnd29dbnwpL65cnaPEk","urlname":"artsavit","employees":"1-10","description":"Cancer Apoptosis Technology","fundingstage":"A","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$F6WXD1F4Qwz7mYtJBrGr3m9mOk5BwIkF3CODnd29dbnwpL65cnaPEk","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6Y9LoLDA","name":"BioSight","hidden":false,"raised":"$62.5M","founded":"1999","fullurl":"/company_page/biosight","logokey":"$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","urlname":"biosight","employees":"1-10","description":"Therapeutics for Oncology and Hematological Disorders","fundingstage":"Acquired","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":62500000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Onxyf8LDA","name":"Kamari Pharma","hidden":false,"raised":"$31M","founded":"2018","fullurl":"/company_page/kamari-pharma","logokey":"$oz90EKLeKCtUu7Af0WmfdyhdWiFbO82jAXi1UpuwvyfsbJn5t7zAu7","urlname":"kamari-pharma","employees":"1-10","description":"Small Molecule Inhibitors of TRPV3","fundingstage":"A","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":31000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$oz90EKLeKCtUu7Af0WmfdyhdWiFbO82jAXi1UpuwvyfsbJn5t7zAu7","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PzOtbwKDA","name":"Lutris Pharma","hidden":false,"raised":"$40.69M","founded":"2015","fullurl":"/company_page/lutris-pharma","logokey":"$BNID6RF5NVT6TmGIdYiKAPmPQqmgeTycxsRYtj8dUuAune2wu8FOYK","urlname":"lutris-pharma","employees":"1-10","description":"Anticancer Therapy for Patients Treated with EGFR Inhibitors","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":40690000,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BNID6RF5NVT6TmGIdYiKAPmPQqmgeTycxsRYtj8dUuAune2wu8FOYK","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL-FiIsKDA","name":"Metabomed","hidden":false,"raised":"$30.5M","founded":"2013","fullurl":"/company_page/metabomed","logokey":"$BjwtNOqkezXTCLNvruNID7f9NgoSHmSQO6JfgmGpZMue3AZ7hhXdRS","urlname":"metabomed","employees":"1-10","description":"Target-inhibiting Anticancer Drugs","fundingstage":"A","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":30500000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BjwtNOqkezXTCLNvruNID7f9NgoSHmSQO6JfgmGpZMue3AZ7hhXdRS","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPXNgr0KDA","name":"Phytolon","hidden":false,"raised":"$20.25M","founded":"2018","fullurl":"/company_page/phytolon","logokey":"$ri6RPG4KHapFaoluZI3lP3uUTwiISQantHFLmtJBiXeyjJ5SSLvXNS.png","urlname":"phytolon","employees":"11-50","description":"Production of Natural Food Colorants","fundingstage":"A","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":20255000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ri6RPG4KHapFaoluZI3lP3uUTwiISQantHFLmtJBiXeyjJ5SSLvXNS.png","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMWF04oKDA","name":"Pi Therapeutics","hidden":false,"raised":"$19.7M","founded":"2015","fullurl":"/company_page/pi-therapeutics","logokey":"$OyG5CyFfWgh7q4iqQSs0SFeZpxjTILEQwYMzLDDlhqDQZnXrM9s79x","urlname":"pi-therapeutics","employees":"1-10","description":"Inhibitors for Cancer Treatment","fundingstage":"B","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":19700000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OyG5CyFfWgh7q4iqQSs0SFeZpxjTILEQwYMzLDDlhqDQZnXrM9s79x","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMX3zZMJDA","name":"Revamp Medical","hidden":true,"raised":"$57K","founded":"2016","fullurl":"/company_page/revamp-medical","logokey":"$UYmczddiy7rLM5xtJYxn09UFvR2rhQMYeLpkJMD95YmczM2ptmwqtz","urlname":"revamp-medical","employees":"11-50","description":"Catheter-based Solution for Acute Decompensated Heart Failure","fundingstage":"A","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":57000,"companyvisibility":"Private","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$UYmczddiy7rLM5xtJYxn09UFvR2rhQMYeLpkJMD95YmczM2ptmwqtz","style":"","hiddenCompanyTooltip":""}],"investments":[{"date":"Aug 2025","name":"Phytolon","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"6cpxREHhKs22tU6OQJIsHm0kE6sxB019wAWmmCxQrwslP9zzVaKTMx","fullurl":"/company_page/phytolon","logokey":"$ri6RPG4KHapFaoluZI3lP3uUTwiISQantHFLmtJBiXeyjJ5SSLvXNS.png","tagline":"Production of Natural Food Colorants","urlname":"/company_page/phytolon","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPXNgr0KDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"gaOGoZi4VjB9wz0EgqfDINX0S3rRrUztTUeN9gs34ulpCjHFhiTd2I","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":null,"leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ri6RPG4KHapFaoluZI3lP3uUTwiISQantHFLmtJBiXeyjJ5SSLvXNS.png","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"May 2023","name":"Revamp Medical","amount":null,"hidden":true,"islead":0,"country":null,"eventid":"vVuO1NEiuLpJY3zKGvFHUj8lBYRTRaNi3ks6dVs8XYYoEhuVk17xsq","fullurl":"/company_page/revamp-medical","logokey":"$UYmczddiy7rLM5xtJYxn09UFvR2rhQMYeLpkJMD95YmczM2ptmwqtz","tagline":"Catheter-based Solution for Acute Decompensated Heart Failure","urlname":"/company_page/revamp-medical","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMX3zZMJDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"A Round","investmentid":"oIxE9SbF2Mo7bl9V1QaUtz7WYofNoC2BmuRLWVzeaBv2TQMLXPNyH5","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$UYmczddiy7rLM5xtJYxn09UFvR2rhQMYeLpkJMD95YmczM2ptmwqtz","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2020","name":"BioSight","amount":27000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODW4J-WCgw","fullurl":"/company_page/biosight","logokey":"$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","tagline":"Therapeutics for Oncology and Hematological Disorders","urlname":"/company_page/biosight","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6Y9LoLDA","isfollowon":1,"companytype":"Startup","eventamount":"$27M","fundingtype":"C Round","investmentid":"229c535c-60cb-4796-aa72-523ab01b0c1f","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Mar 2020","name":"BioSight","amount":19000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD94NOfCAw","fullurl":"/company_page/biosight","logokey":"$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","tagline":"Therapeutics for Oncology and Hematological Disorders","urlname":"/company_page/biosight","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6Y9LoLDA","isfollowon":1,"companytype":"Startup","eventamount":"$19M","fundingtype":"C Round","investmentid":"36f094ac-3be2-4fd0-8824-d64c90a4cff1","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Mar 2020","name":"Lutris Pharma","amount":5690000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCe6tOZCAw","fullurl":"/company_page/lutris-pharma","logokey":"$BNID6RF5NVT6TmGIdYiKAPmPQqmgeTycxsRYtj8dUuAune2wu8FOYK","tagline":"Anticancer Therapy for Patients Treated with EGFR Inhibitors","urlname":"/company_page/lutris-pharma","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PzOtbwKDA","isfollowon":1,"companytype":"Startup","eventamount":"$5.69M","fundingtype":"Undisclosed Round","investmentid":"86d925ca-a618-4672-ad1f-fd7dd625754f","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BNID6RF5NVT6TmGIdYiKAPmPQqmgeTycxsRYtj8dUuAune2wu8FOYK","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2020","name":"Kamari Pharma","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODp8fiWCAw","fullurl":"/company_page/kamari-pharma","logokey":"$oz90EKLeKCtUu7Af0WmfdyhdWiFbO82jAXi1UpuwvyfsbJn5t7zAu7","tagline":"Small Molecule Inhibitors of TRPV3","urlname":"/company_page/kamari-pharma","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Onxyf8LDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"2e8c322e-9299-49d3-8476-772200cec79d","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$oz90EKLeKCtUu7Af0WmfdyhdWiFbO82jAXi1UpuwvyfsbJn5t7zAu7","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2019","name":"Metabomed","amount":12500000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODa5oLnCQw","fullurl":"/company_page/metabomed","logokey":"$BjwtNOqkezXTCLNvruNID7f9NgoSHmSQO6JfgmGpZMue3AZ7hhXdRS","tagline":"Target-inhibiting Anticancer Drugs","urlname":"/company_page/metabomed","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL-FiIsKDA","isfollowon":1,"companytype":"Startup","eventamount":"$12.5M","fundingtype":"Undisclosed Round","investmentid":"cac1a44f-75eb-47e8-81a4-2089b5315607","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BjwtNOqkezXTCLNvruNID7f9NgoSHmSQO6JfgmGpZMue3AZ7hhXdRS","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"May 2019","name":"Pi Therapeutics","amount":19700000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCU79qTCQw","fullurl":"/company_page/pi-therapeutics","logokey":"$OyG5CyFfWgh7q4iqQSs0SFeZpxjTILEQwYMzLDDlhqDQZnXrM9s79x","tagline":"Inhibitors for Cancer Treatment","urlname":"/company_page/pi-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMWF04oKDA","isfollowon":0,"companytype":"Startup","eventamount":"$19.7M","fundingtype":"B Round","investmentid":"de8c4a0d-862f-4109-8f23-f8822603a708","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OyG5CyFfWgh7q4iqQSs0SFeZpxjTILEQwYMzLDDlhqDQZnXrM9s79x","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2017","name":"ARTSaVIT","amount":6300000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD42YWBCQw","fullurl":"/company_page/artsavit","logokey":"$F6WXD1F4Qwz7mYtJBrGr3m9mOk5BwIkF3CODnd29dbnwpL65cnaPEk","tagline":"Cancer Apoptosis Technology","urlname":"/company_page/artsavit","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMW95ZgKDA","isfollowon":0,"companytype":"Startup","eventamount":"$6.3M","fundingtype":"A Round","investmentid":"4156ed6b-3e71-4081-9c26-338040ea474e","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Private","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='\n\n
\n \n \n Private\n
'","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$F6WXD1F4Qwz7mYtJBrGr3m9mOk5BwIkF3CODnd29dbnwpL65cnaPEk","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jun 2016","name":"Lutris Pharma","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD8zYmcCQw","fullurl":"/company_page/lutris-pharma","logokey":"$BNID6RF5NVT6TmGIdYiKAPmPQqmgeTycxsRYtj8dUuAune2wu8FOYK","tagline":"Anticancer Therapy for Patients Treated with EGFR Inhibitors","urlname":"/company_page/lutris-pharma","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PzOtbwKDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"19922a9d-6e78-4453-aa7e-5bef87a9912b","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BNID6RF5NVT6TmGIdYiKAPmPQqmgeTycxsRYtj8dUuAune2wu8FOYK","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"May 2016","name":"BioSight","amount":13000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODknsCTCQw","fullurl":"/company_page/biosight","logokey":"$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","tagline":"Therapeutics for Oncology and Hematological Disorders","urlname":"/company_page/biosight","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6Y9LoLDA","isfollowon":0,"companytype":"Startup","eventamount":"$13M","fundingtype":"B Round","investmentid":"688c2727-fb69-433d-b5b8-210486065d5a","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$SqyTguoYN862q8mFdZlPDLGotRL76WAcHPB1YM5V7Ecl4cRSyZLcJu","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Apr 2016","name":"Metabomed","amount":18000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmt3nCQw","fullurl":"/company_page/metabomed","logokey":"$BjwtNOqkezXTCLNvruNID7f9NgoSHmSQO6JfgmGpZMue3AZ7hhXdRS","tagline":"Target-inhibiting Anticancer Drugs","urlname":"/company_page/metabomed","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL-FiIsKDA","isfollowon":0,"companytype":"Startup","eventamount":"$18M","fundingtype":"A Round","investmentid":"d8f379d9-8f13-4fe5-88c0-57852db22cdc","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$BjwtNOqkezXTCLNvruNID7f9NgoSHmSQO6JfgmGpZMue3AZ7hhXdRS","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""}],"team":[{"name":"Dr. Pini Orbach","email":"pini@arkinholdings.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoLWYk5sJDA","bounced":false,"claimed":0,"founder":1,"urlname":"dr-pini-orbach","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg5bLB3ggM","position":"Managing Partner","last_name":"Orbach","claimtoken":"f54301ee696886c05f1120679eddf3fb897c7b1873afd661121b292085a658e6","first_name":"Dr. Pini","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/pini-orbach-6bb6071/","unsubscribed":true,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"DO","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dr. Alon Lazarus","email":"alon@arkinholdings.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNmAqK8IDA","bounced":false,"claimed":0,"founder":0,"urlname":"dr-alon-lazarus","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg1u-ZlwoM","position":"Biotech Investment Manager","last_name":"Lazarus","claimtoken":"569dd917dd39d290fc05e984cee41bccb82b9664d0c0d1c641e386b1f7ade259","first_name":"Dr. Alon","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/alon-lazarus-8b522a49/","unsubscribed":true,"is_activeuser":1,"additionalemail":"alon@explorebio.co.il","claimedemaildate":null,"initials":"DL","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shir Taushtein","email":"shir@arkin-capital.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkIKn-PcKDA","bounced":false,"claimed":null,"founder":0,"urlname":"shir-taushtein-1","visible":1,"memberid":"dEFHNpKIQDeV7moyOVFIuVUoZMXmabSH6LlRU6CcAVKbZRdiFsrvOU","position":"Communication & IR","last_name":"Taushtein","claimtoken":"qvEFuPyzbKdfiaRZjVGmfvFvuB50IZFFGepNzC6XcPl52W4wEQS9MZ","first_name":"Shir","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shir-taushtein-596874152/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2025-05-27 07:19:18.000000","initials":"ST","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Maxim Katsenelson","email":"maxim@arkin-capital.com","phone":"","gender":"Male","userid":"lbx3x1v37vszRT4z7DHOx96mmG8dKe5izoY1GHjRbdXeftih37qtCb","bounced":false,"claimed":1,"founder":0,"urlname":"maxim-katsenelson-1","visible":1,"memberid":"KhYjoZYR5iCtjx9Uoh473QTRhRiLzVmvTm4p7DxYrZAMHJjom5cmqT","position":"","last_name":"Katsenelson","claimtoken":"wkhj4zhDDmfuPtJ9uJlL5SPfnVAsQ6WeWxmEEgmZbhGeEgRPZ6TROn","first_name":"Maxim","picturekey":null,"claimeddate":"2025-05-27","linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2025-05-27 07:20:30.000000","initials":"MK","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"tags":["healthcare","microbiome","cancer","immunotherapy","biotechnology","pharmaceuticals","cns-disorders","oncology","drug-delivery","autoimmune-diseases"],"targetmarkets":[],"phone":null,"address":{"israeli":[{"id":"af1845e3-d3e3-4075-904a-12b621923657","city":"Herzliya","type":null,"address":"Ha-Menofim St 11, Herzliya, Israel","placeid":"ChIJw_jyjvJIHRUReWGAJhuwpjw","notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[]},"headquarter_address":"","news":[{"id":"909eeaa9-5023-4d8b-bd40-cfeffd55e508","date":"Mar 9, 2020","link":"https://www.fiercebiotech.com/biotech/arkin-holdings-phoenix-group-unite-again-140m-biotech-fund","source":"www.fiercebiotech.com","visible":1,"analysis":{"tags":"N/A","company":"Questex LLC","layoffs":"N/A","summary":"The article does not provide any information about Questex LLC or any relevant events.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":10,"key_topics":[],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"N/A","investment_amount":"N/A","structured_issues":[],"acquisition_amount":"N/A","entityGrowthIconPath":"none;"},"sentiment":"N/A","analysisId":"0GJ8ONpaKjpp7nhmuTtXDPQtOfskmO84AhLCGkf36vHk8dF8kiXgDq","news_summary":"https://www.fiercebiotech.com/biotech/arkin-holdings-phoenix-group-unite-again-140m-biotech-fund","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"def4c5af-e9ec-4157-b7f7-13fdd79f3acf","date":"Jun 16, 2016","link":"https://www.prnewswire.com/news-releases/arkin-holdings-and-phoenix-group-announce-a-strategic-collaboration-that-will-invest-approximately-60-million-in-pharma-and-biotech-companies-583266301.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Investment, Partnership","company":"Phoenix Group and Arkin Holdings","layoffs":"N/A","summary":"Phoenix Group and Arkin Holdings have announced a Strategic Collaboration Agreement for investment in pharma and biotech companies, totalling approximately $60 million. The new partnership, Arkin Bio-Ventures, aims to invest in companies that develop promising innovative pharmaceuticals in pre-clinical and more advanced stages, both in Israel and globally. This is the largest investment ever made by the Phoenix Group in private pharma companies, and the first time its Investment Division promotes such an extensive life science collaboration.","partners":"Arkin Holdings","customers":"N/A","investors":"Phoenix Group and Arkin Holdings","confidence":9,"key_topics":["Investment","Pharma","Biotech","Partnership","Life Science"],"date_of_event":"June 16, 2016","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"$60 million","structured_issues":["Investment","Partners"],"acquisition_amount":"N/A","structuredIssuesShow":"#Investment #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ewqtg5uwiUVFYiFNJssfZe6C9NLHk5IzTEHNkKq964HYR678fVKSzo","news_summary":"Arkin Holdings and Phoenix Group Announce a Strategic Collaboration That Will Invest Approximately $60 Million in Pharma and Biotech Companies","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":2,"mediagallery":[],"biverification":"Jenny Sotnik-Talisman","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2020-03-09T00:00:00.000Z","crunchbaseid":"arkin-bio-ventures","lastupdator":"Yotam Maman","lastupdator_email":"yotamm1988@gmail.com","creator":"Yotam Maman","creator_email":"yotamm1988@gmail.com","createdate":"2018-07-29T00:00:00.000Z","recentupdates":[{"email":"doron.b@sncentral.org","source":"Manual","datetime":"2025-05-27 07:20:30.000000","last_name":"Bobman","first_name":"Doron"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-02-08 10:19:57.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:08.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-10 10:45:58.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-10 10:45:58.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"doron.b@sncentral.org","source":"Manual","datetime":"2025-05-27 07:20:30.000000","last_name":"Bobman","first_name":"Doron"},{"email":"doron.b@sncentral.org","source":"Manual","datetime":"2025-05-27 07:18:37.000000","last_name":"Bobman","first_name":"Doron"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-02-08 10:20:15.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Automatic","datetime":"2024-07-16 07:32:13.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-03-11 09:50:55.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:11.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-02-08 10:19:14.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Automatic","datetime":"2024-07-16 07:32:09.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:09.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-03-11 09:50:55.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"maxim@arkin-capital.com","source":"Manual","datetime":"2025-05-27 09:50:44.000000","last_name":"Katsenelson","first_name":"Maxim"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-03-11 09:50:55.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-07-17 17:04:44.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:08.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-07-23 08:58:16.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-02-08 10:19:57.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:08.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-03-11 09:50:55.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"doron.b@sncentral.org","source":"Manual","datetime":"2025-05-27 07:20:24.000000","last_name":"Bobman","first_name":"Doron"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-02-08 10:19:20.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:08.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-02-08 10:19:20.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Automatic","datetime":"2024-07-16 07:32:09.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:08:13.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:13:23.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:13:28.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:08:43.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:15:18.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:08:14.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:13:25.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:16:05.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 08:57:41.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 08:57:41.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 08:57:41.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 08:57:41.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 08:57:41.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 08:57:41.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 08:57:41.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:08:51.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:08:15.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:08:15.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:08:15.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:13:27.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:13:24.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:13:37.000000","last_name":"Maman","first_name":"Yotam"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2018-08-13 11:14:35.000000","last_name":"McCandless","first_name":"Katie"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2018-08-13 11:14:35.000000","last_name":"McCandless","first_name":"Katie"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2018-08-05 09:23:31.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2018-08-05 09:23:31.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:13:29.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:10:57.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:12.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:04:12.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 10:08:20.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:13:36.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:08:29.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:11:33.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:11:33.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:13:22.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:06:01.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:09:12.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:13:23.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-07-29 09:08:57.000000","last_name":"Maman","first_name":"Yotam"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2019-04-22 12:41:04.000000","last_name":"McCandless","first_name":"Katie"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2019-04-22 12:41:05.000000","last_name":"McCandless","first_name":"Katie"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-08-01 12:01:17.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-01-25 07:45:18.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-01-25 07:53:53.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-01-25 07:53:28.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-03-09 16:33:40.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-03-09 16:34:29.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-03-09 16:40:09.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-08-01 12:02:56.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-08-01 12:02:56.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-01-25 07:44:28.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-01-25 07:45:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-08-19 06:30:00.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-03-09 16:42:17.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-03-09 16:30:58.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-08-01 12:05:00.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-08-01 12:03:03.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-01-25 07:53:33.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-03-09 16:39:40.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-03-09 16:39:40.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-03-09 16:39:40.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-03-09 16:31:03.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-08-01 12:10:22.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-08-05 05:17:26.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-03-09 16:31:18.000000","last_name":"Maman","first_name":"Yotam"},{"email":"doron.b@sncentral.org","source":"Manual","datetime":"2025-05-27 07:19:13.000000","last_name":"Bobman","first_name":"Doron"},{"email":"shir@arkinholdings.com","source":"Automatic","datetime":"2024-07-16 07:32:13.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"maxim@arkin-capital.com","source":"Manual","datetime":"2025-05-27 09:50:44.000000","last_name":"Katsenelson","first_name":"Maxim"},{"email":"doron.b@sncentral.org","source":"Manual","datetime":"2025-05-27 07:20:24.000000","last_name":"Bobman","first_name":"Doron"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:11.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-10 10:45:58.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:08.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"doron.b@sncentral.org","source":"Manual","datetime":"2025-05-27 07:19:18.000000","last_name":"Bobman","first_name":"Doron"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:12.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"doron.b@sncentral.org","source":"Manual","datetime":"2025-05-27 07:19:18.000000","last_name":"Bobman","first_name":"Doron"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-07-17 17:04:49.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-02-08 10:19:57.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"maxim@arkin-capital.com","source":"Manual","datetime":"2025-05-27 09:50:44.000000","last_name":"Katsenelson","first_name":"Maxim"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-02-08 10:20:15.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:12.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"maxim@arkin-capital.com","source":"Manual","datetime":"2025-05-27 09:50:44.000000","last_name":"Katsenelson","first_name":"Maxim"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2025-06-10 10:45:58.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"doron.b@sncentral.org","source":"Manual","datetime":"2025-01-28 09:27:42.000000","last_name":"Bobman","first_name":"Doron"},{"email":"doron.b@sncentral.org","source":"Manual","datetime":"2025-05-27 07:19:13.000000","last_name":"Bobman","first_name":"Doron"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-07-17 17:04:49.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:09.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:08.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"shir@arkinholdings.com","source":"Automatic","datetime":"2024-07-16 07:32:09.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2023-01-02 13:12:43.000000","last_name":"Wein","first_name":"Ortal"},{"email":"shir@arkinholdings.com","source":"Manual","datetime":"2024-07-16 07:32:12.000000","last_name":"Taushtein","first_name":"Shir"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-02-08 10:19:20.000000","last_name":"Wein","first_name":"Ortal"}],"rounds_per_sector":[{"count":11,"sector":"Health Tech & Life Sciences"},{"count":1,"sector":"Agriculture & Food Technologies"}],"rounds_per_stage":[{"count":3,"isfollowon":0,"fundingStage":"A Round"},{"count":2,"isfollowon":0,"fundingStage":"B Round"},{"count":2,"isfollowon":1,"fundingStage":"C Round"},{"count":3,"isfollowon":0,"fundingStage":"Undisclosed"},{"count":2,"isfollowon":1,"fundingStage":"Undisclosed"}],"investment_rounds_over_time":[{"year":2016,"month":4,"record_count":1},{"year":2016,"month":5,"record_count":1},{"year":2016,"month":6,"record_count":1},{"year":2017,"month":1,"record_count":1},{"year":2019,"month":5,"record_count":1},{"year":2019,"month":12,"record_count":1},{"year":2020,"month":1,"record_count":1},{"year":2020,"month":3,"record_count":2},{"year":2020,"month":12,"record_count":1},{"year":2023,"month":5,"record_count":1},{"year":2025,"month":8,"record_count":1}],"portfolio_companies_per_sector":[{"count":7,"sector":"Health Tech & Life Sciences"},{"count":1,"sector":"Agriculture & Food Technologies"}],"new_portfolio_companies_over_time":[{"year":2016,"month":4,"record_count":1},{"year":2016,"month":5,"record_count":1},{"year":2016,"month":6,"record_count":1},{"year":2017,"month":1,"record_count":1},{"year":2019,"month":5,"record_count":1},{"year":2020,"month":1,"record_count":1},{"year":2023,"month":5,"record_count":1},{"year":2025,"month":8,"record_count":1}],"exits_over_time":[{"year":2023,"count":3,"eventType":"MNAEvent"}],"exits_by_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"affiliatedOrganizations":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JeSxIAKDA","name":"Arkin Digital Health","type":"Investor","hidden":false,"fullurl":"/investor_page/arkin-digital-health","logokey":"$PKm1p9Y88k2KGO8TO5ytZ69w16mEnjCTdsrK6bOVoTADqzuEWDPyoD.png","logourl":"https://storage.googleapis.com/clean-finder-353810/$PKm1p9Y88k2KGO8TO5ytZ69w16mEnjCTdsrK6bOVoTADqzuEWDPyoD.png","onClick":"","visibilityClassName":"","visibilityTooltip":""}],"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCOjqv2CQw","date":"2020-03-01","name":"2","title":"Fund 2","amount":140000000,"source":"https://www.fiercebiotech.com/biotech/arkin-holdings-phoenix-group-unite-again-140m-biotech-fund","eventtype":"InvestmentFirmFundingEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":null,"style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD2krrhCAw","date":"2016-06-01","name":"1","title":"Fund 1","amount":60000000,"source":"https://www.prnewswire.com/news-releases/arkin-holdings-and-phoenix-group-announce-a-strategic-collaboration-that-will-invest-approximately-60-million-in-pharma-and-biotech-companies-583266301.html","eventtype":"InvestmentFirmFundingEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":null,"style":"","hiddenCompanyTooltip":""}],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"VC and Private Equity","parsedName":"Arkin Bio","logourl":"/assets/investors-icon.svg","oglogourl":"http://localhost/assets/snc_logo.svg","teamMembersNumber":4,"section":null,"sectionParams":"","queryParams":"","seoabout":"Arkin Bio is an activity of Arkin Capital, a multi-billion-dollar VC, PE and Hedge Funds manager, targeting both early-stage and late-stage investments in ...","seoTitle":"Israeli VC and Private Equity","serializedCharts":"{\"investmentsRoundsByRoundType\":[{\"fundingStage\":\"A Round\",\"newInvestments\":3,\"followOnInvestments\":0},{\"fundingStage\":\"B Round\",\"newInvestments\":2,\"followOnInvestments\":0},{\"fundingStage\":\"C Round\",\"newInvestments\":0,\"followOnInvestments\":2},{\"fundingStage\":\"Undisclosed\",\"newInvestments\":3,\"followOnInvestments\":2}],\"investmentRoundsBySector\":[{\"count\":11,\"sector\":\"Health Tech & Life Sciences\"},{\"count\":1,\"sector\":\"Agriculture & Food Technologies\"}],\"investmentRoundsOverTime\":[{\"label\":\"2016\",\"count\":3},{\"label\":\"2017\",\"count\":1},{\"label\":\"2018\",\"count\":0},{\"label\":\"2019\",\"count\":2},{\"label\":\"2020\",\"count\":4},{\"label\":\"2021\",\"count\":0},{\"label\":\"2022\",\"count\":0},{\"label\":\"2023\",\"count\":1},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":1},{\"label\":\"2026\",\"count\":0}],\"portfolioCompaniesBySector\":[{\"count\":7,\"sector\":\"Health Tech & Life Sciences\"},{\"count\":1,\"sector\":\"Agriculture & Food Technologies\"}],\"portfolioCompaniesOverTime\":[{\"label\":\"2016\",\"count\":3},{\"label\":\"2017\",\"count\":1},{\"label\":\"2018\",\"count\":0},{\"label\":\"2019\",\"count\":1},{\"label\":\"2020\",\"count\":1},{\"label\":\"2021\",\"count\":0},{\"label\":\"2022\",\"count\":0},{\"label\":\"2023\",\"count\":1},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":1},{\"label\":\"2026\",\"count\":0}],\"exitsOverTime\":[{\"year\":2023,\"count\":3,\"eventType\":\"MNAEvent\"},{\"year\":2016,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2016,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2017,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2017,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2018,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2018,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2019,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2019,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2020,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2020,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2021,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2021,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2022,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2022,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2024,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2024,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2025,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2025,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2026,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2026,\"count\":0,\"eventType\":\"publicExits\"}],\"exitsBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}]}","statusinfo":"","iiasupport":"","managedAssetsNumber":null,"investmentrange":"$5.69M - $27M","communityinvolvement":[],"foreignInvestments":"","nationality":"Israeli","investorStatistics":{"exitRatio":{"amount":"0"},"investmentFollowOnRatio":{"amount":""},"leadInvestorShare":{"amount":"0"},"soloInvestmentRoundRatio":{"amount":"0"},"firstInvestorRatio":{"amount":"0"}},"popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none"},"mainContact":{}}